We are pleased to announce that, after 2015 and 2016, the DeepChek®-HIV RT/PROT assay and the DeepChek®-HIV INT assay successfully passed a national quality control program in France, Switzerland and emerging countries (ANRS CQ 2017) through an independent lab and obtained 100% positive results on sensibility, 100% on specificity and also 100% on scoring on HIV genotyping & drug resistance assessments and interpretations.
DeepChek®-HIV RT/PROT and DeepChek®-HIV INT Genotyping Assays Successfully Passed 2017 National Quality Control Program with 100% Accuracy.
Oct 15, 2018